Home >> Life Sciences >> Healthcare

Global Genetic Testing Market Outlook - Growth, Trends and Forecasts 2017 - 2022

Published: Jul-2015 | Format: PDF | Stratistics MRC | Number of pages: 90 | Code: MRS - 28326

The Global Genetic Testing Market accounted for $3.2 billion in 2014 and is expected to grow at a CAGR of 9.26% to reach $6.5 billion by 2022. The factors contributing to the market growth include aging population, growing awareness, availability of direct to consumer tests and increasing incidence of genetic disorder. However factors such as high cost for testing and reimbursement issues are inhibiting the growth of the market. Genetic testing for cancer is likely to be the fastest growing segment during the forecast period. Increasing incidence of genetic diseases is providing more opportunities for genetic testing along with the rise in personalized medicine. The federal agencies who play a significant role in regulating genetic tests are Food and Drug Administration (FDA), Federal Trade Commission (FTC) and Center for Medicare and Medicaid services (CMS).

Global Genetic Testing Market is segmented on the basis of application and geography. By Application, the market is categorized into Cancer Genetic Testing Market, Prenatal Genetic Testing Market, Pharmacogenomics Genetic Testing Market and Predisposition Cancer Genetic Testing Market. By geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America leads the Genetic Testing Market followed by Europe.

Some of the key players in Genetic Testing Market include Abbott Laboratories, Biocartis SA, Applied Biosystems Inc., Celera Group, AutoGenomics Inc., Roche Diagnostics Limited, IntegraGen S.A, Transgenomic, Inc., Molecular Inc. and Luminex Corporation.

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5Global Genetic TestingMarket, By Applications 
5.1 Cancer Genetic Testing Market
5.2 Prenatal Genetic Testing Market 
5.3 Pharmacogenomics Genetic Testing Market
5.4 Predisposition Cancer Genetic Testing Market 

6 Global Genetic TestingMarket, By Geography 
6.1 North America
6.1.1 US
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 Newzealand
6.3.6 Rest of Asia
6.4 Rest of the World
6.4.1 Latin America
6.4.2 Middle East
6.4.3 Africa
6.4.4 Others

7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures 
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies

8 Company Profiling
8.1 Abbott Laboratories
8.2 Biocartis SA
8.3 Applied Biosystems Inc.
8.4 Celera Group
8.5 AutoGenomics Inc.
8.6 Roche Diagnostics Limited 
8.7 IntegraGen S.A
8.8 Transgenomic, Inc.
8.9 Molecular Inc. 
8.10 Luminex Corporation

List of Tables
1 Global Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
2 Global Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
3 Global Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
4 Global Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
5 Global Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
6 North America Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
7 North America Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
8 North America Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
9 North America Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
10 North America Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
11 Europe Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
12 Europe Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
13 Europe Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
14 Europe Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
15 Europe Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
16 Asia Pacific Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
17 Asia Pacific Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
18 Asia Pacific Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
19 Asia Pacific Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
20 Asia Pacific Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
21 Rest Of The World Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
22 Rest Of The World Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
23 Rest Of The World Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
24 Rest Of The World Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
25 Rest Of The World Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

North America Insulin Pen Needles Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 116 | Code : MRS-193124 | 4480

Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections. Read more

North America Human Milk Oligosaccharides (HMO) Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 115 | Code : MRS-193123 | 4480

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Scope of the Report: This report focuses on the Human Milk Oligosaccharides (HMO) in North America marke Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Surgical Blades & Scalpels Market 2017 Forecast to 2022

Dec-2017 | Global Info Research | Pages : 117 | Code : MRS-193122 | 4880

Surgical Scalpel is a small and extremely sharp bladed instrument used for surgery, anatomical dissection, and various arts and crafts (called a hobby knife). Scalpels may be single-use disposable or re-usable. Re-usable scalpels can have permanently attached blades that can be sharpened or, more commonly, removable single-use blades. Disposable scalpels usually have a plastic handle with an extensible blade (like a utility knife) and are used once, then the entire instrument is discarded. Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Electromagnetic Therapy Device Market 2017 Forecast to 2022

Dec-2017 | Global Info Research | Pages : 124 | Code : MRS-193121 | 4880

Electromagnetic therapy is a pseudoscientific form of alternative medicine which claims to treat disease by applying electromagnetic radiation to the body. Scope of the Report: This report focuses on the Electromagnetic Therapy Device in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Read more

2017-2022 United States Pain Relief Patches Market Report (Status and Outlook)

Dec-2017 | LPI (LP Information) | Pages : 121 | Code : MRS-193056 | 3360

In 2016, the Pain Relief Patches market size was xx million in United States, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include Hisamitsu Mylan Johnson & Johnson Actavis Lingrui Teikoku Seiyaku Sanofi Novartis Qizheng Endo Huarun 999 GSK Haw Par Nichiban Mentholatum Company Laboratoires Genevrier BLUE-EMU Split by product type Read more

2017-2022 United States Anthrax Vaccines Market Report (Status and Outlook)

Dec-2017 | LPI (LP Information) | Pages : 116 | Code : MRS-193055 | 3360

In 2016, the Anthrax Vaccines market size was xx million in United States, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include Emergent BioSolutions Merial Merck Zoetis Bayer Sanidad Animal Colorado Serum PharmAthene Tiankang Biogénesis-Bago CAVAC Rosenbusch Agrovet Vecol CVCRI IVPM Prondil CDV Indian Immunologicals Botsw Read more

2017-2022 North America Pain Relief Patches Market Report

Dec-2017 | LPI (LP Information) | Pages : 121 | Code : MRS-193054 | 4660

In 2016, the North America Pain Relief Patches market size was xx million and it will reach xx million in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Pain Relief Patches in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering Hisamitsu Mylan Johnson & Johnson Actavis Lingrui Teikoku Seiyaku Sanofi Novartis Qizheng Endo Huarun 999 GSK Read more

2017-2022 North America Anthrax Vaccines Market Report

Dec-2017 | LPI (LP Information) | Pages : 116 | Code : MRS-193053 | 4660

In 2016, the North America Anthrax Vaccines market size was xx million and it will reach xx million in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Anthrax Vaccines in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering Emergent BioSolutions Merial Merck Zoetis Bayer Sanidad Animal Colorado Serum PharmAthene Tiankang Biogénesis-Bago CAVAC Ro Read more

2017-2022 India Pain Relief Patches Market Report (Status and Outlook)

Dec-2017 | LPI (LP Information) | Pages : 121 | Code : MRS-193052 | 3360

In 2016, the Pain Relief Patches market size was xx million in China, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include Hisamitsu Mylan Johnson & Johnson Actavis Lingrui Teikoku Seiyaku Sanofi Novartis Qizheng Endo Huarun 999 GSK Haw Par Nichiban Mentholatum Company Laboratoires Genevrier BLUE-EMU Split by product types/category, cov Read more

2017-2022 India Anthrax Vaccines Market Report (Status and Outlook)

Dec-2017 | LPI (LP Information) | Pages : 116 | Code : MRS-193051 | 3360

In 2016, the Anthrax Vaccines market size was xx million in China, and it will be xx million in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include Emergent BioSolutions Merial Merck Zoetis Bayer Sanidad Animal Colorado Serum PharmAthene Tiankang Biogénesis-Bago CAVAC Rosenbusch Agrovet Vecol CVCRI IVPM Prondil CDV Indian Immunologicals Botswana Vaccine Ins Read more

Single User | $(USD)4150 View Pricing